Background illustration for clinical trials search

Ulcerative Colitis Clinical Trials

Browse 237 Ulcerative Colitis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

for
Ulcerative Colitis (UC)
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT07427017

Phase 2, Recruiting

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: Hartford CT, Lake Success NY, New York NY, Toronto,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 2 - 17

Code: NCT07158242

Phase 3, Recruiting

Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), UC - Ulcerative Colitis
Location: Montreal
Sponsor: Odyssey Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06850727

Phase 2, Recruiting

Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis

for
Ulcerative Colitis Acute
Location: Ann Arbor MI
Sponsor: Berinstein, Jeffrey

Sex: All

Age: 18 - 70+

Code: NCT07258771

Recruiting

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Severe Ulcerative Colitis,
Location: Providence RI, Bristol CT, Clifton NJ, Albany NY,
Sponsor: Palisade Bio

Sex: All

Age: 18 - 70+

Code: NCT07845487

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

for
Renal Cell Carcinoma, Non Small Cell Lung Cancer, Melanoma,
Location: Pittsburgh PA
Sponsor: Diwakar Davar

Sex: All

Age: 18+

Code: NCT07223424

Phase 2, Recruiting

STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

for
Ulcerative Colitis (UC)
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18 - 70+

Code: NCT06693310

Recruiting

Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC)
Location: Nashville TN, Chula Vista CA
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07686081

Phase 3, Recruiting

Study of Novel Therapeutics for Acute Remedy of Colitis

for
Ulcerative Colitis, Ulcerative Colitis Chronic Moderate,
Location: Chestnut Hill MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 70+

Code: NCT06420492

Phase 2, Recruiting

Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation

for
Ulcerative Colitis, Ileal Pouch
Location: Ann Arbor MI
Sponsor: Muhammad N Aslam, MD

Sex: All

Age: 18 - 70+

Code: NCT07501078

Phase 2, Recruiting

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

for
Ulcerative Colitis, Crohn's Disease
Location: Oklahoma City OK
Sponsor: Takeda

Sex: All

Age: 2 - 17

Code: NCT06405087

Phase 3, Recruiting

A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

for
Ulcerative Colitis
Location: Wilmington NC
Sponsor: Bristol-Myers Squibb

Sex: Female

Age: 0+

Code: NCT05953402

Recruiting

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

for
Ulcerative Colitis
Location: Miami FL, Kissimmee FL, Charlotte NC, Lakewood Rch FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT06636656

Phase 2, Recruiting

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

for
Colitis, Ulcerative
Location: Quebec, New York NY, Indianapolis IN, Winnipeg
Sponsor: Pfizer

Sex: All

Age: 2 - 11

Code: NCT07470879

Phase 2, Recruiting

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

for
Colitis Ulcerative, Ulcerative Colitis
Location: Montreal, Miami FL, Toronto, Orlando FL, Inverness FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07463183

Phase 2, Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

for
Ulcerative Colitis
Location: London, Fresh Meadows NY, Montreal, Rochester NY,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06979336

Phase 2, Recruiting

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

for
Ulcerative Colitis
Location: Morristown NJ, Philadelphia PA, Miami FL, Pittsburgh PA,
Sponsor: AbbVie

Sex: All

Age: 2 - 17

Code: NCT07071519

Phase 3, Recruiting

Treatment of UC With Novel Therapeutics

for
Ulcerative Colitis Mild, Ulcerative Colitis
Location: Chestnut Hill MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 70+

Code: NCT06420375

Phase 2, Recruiting

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

for
Crohn's Disease, Ulcerative Colitis
Location: Glen Burnie MD, Tyler TX
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06764615

Phase 2, Recruiting

Personalized Anti-Inflammatory Fibres in Ulcerative Colitis

for
Ulcerative Colitis
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 14+

Code: NCT06515210

Recruiting

What is ulcerative colitis?

Ulcerative colitis, or UC, is a form of inflammatory bowel disease. Abnormal reactions of the immune system cause inflammation and open sores called ulcers on the inner lining of the large intestine, meaning the colon and the rectum. That leads to diarrhea, blood in the stool, and belly pain. UC doesn't only affect the colon either. It's linked to higher rates of arthritis, and specifically to ankylosing spondylitis and psoriasis, conditions doctors call extraintestinal manifestations of the disease. It most often starts between ages 15 and 30, though it can begin at any age. About 1.25 million Americans have been diagnosed with UC, which makes it the more common form of IBD in adults, slightly ahead of Crohn's disease.

Research in this field has its own shape. Most UC studies check whether a drug worked with a colonoscopy or sigmoidoscopy at set visits, because it is not enough for a person to feel better, a camera has to show the colon lining healing. That is also why UC trials run in two stages, one to see if the drug works fast and a longer one to see if the effect lasts. And there is a gap the field wants to close: UC affects every racial and ethnic group, but Black, Hispanic, and Asian patients are still underrepresented in IBD research, so many studies actively welcome them.

Article preview image

Interested in learning more about Entyvio? Read our guide: Entyvio Side Effects: A Patient Guide

Entyvio Not Working Well Enough? Side Effects, Timing, and Next Steps

Forms and severity of ulcerative colitis, and why they matter for trials

Can ulcerative colitis be cured?

Is ulcerative colitis genetic?

Types of trials used for ulcerative colitis

Who can participate in ulcerative colitis clinical trials?

How to enroll in an ulcerative colitis clinical trial